RNA Nanobiotics was established to advance the RNA nanoparticle technology developed by Dr. Peixuan Guo at Ohio State University into an innovative targeted delivery system able to improve the therapeutic outcome of patients with cancer. Our proprietary RNA Nanotechnology Platform allows for Targeted Delivery of RNAi, Radioisotopes and Chemotherapeutics for safe and effective cancer treatments. The nanoparticles are made of synthetic RNA and are engineered to contain aptamer targeting sequences, modified nucleoside drugs and microRNA and RNAi drugs into the nan o particles which morph into the drugs when they reach and are incorporated into the target cells.